$ANIP
ANI Pharmaceuticals Inc Stock $anip

$anip Overview Financials Valuation SEC Filings Company Website

2017 Q2 Form 10-Q Financial Statement

#000114420417040342 Filed on August 03, 2017

Income Statement

Concept	2017 Q2	2016 Q4	2016 Q2
Revenue	$44.76M	$38.21M	$31.34M
YoY Change	42.85%	111.84%	60.57%
Cost Of Revenue	$21.12M	$16.91M	$11.80M
YoY Change	79.08%	377.68%	275.52%
Gross Profit	$23.64M	$21.30M	$19.54M
YoY Change	20.98%	46.9%	19.34%
Gross Profit Margin	52.81%	55.75%	62.36%
Selling, General & Admin	$7.380M	$7.370M	$7.628M
YoY Change	-3.25%	34.98%	37.42%
% of Gross Profit	31.22%	34.6%	39.03%
Research & Development	$2.167M	$140.0K	$764.0K
YoY Change	183.64%	-78.79%	-23.22%
% of Gross Profit	9.17%	0.66%	3.91%
Depreciation & Amortization	$7.101M	$5.810M	$5.956M
YoY Change	19.22%	175.36%	320.92%
% of Gross Profit	30.04%	27.28%	30.48%
Operating Expenses	$9.547M	$13.31M	$8.392M
YoY Change	13.76%	61.73%	28.2%
Operating Profit	$6.994M	$1.298M	$5.194M
YoY Change	34.66%	-79.29%	-38.27%
Interest Expense	-$3.025M	-$2.860M	-$2.830M
YoY Change	6.89%	3.25%	2.95%
% of Operating Profit	-43.25%	-220.34%	-54.49%
Other Income/Expense, Net	-$19.00K	-$40.00K	-$12.00K
YoY Change	58.33%
Pretax Income	$3.950M	-$1.600M	$2.352M
YoY Change	67.94%	-145.71%	-58.48%
Income Tax	-$1.269M	$524.0K	-$1.227M
% Of Pretax Income	-32.13%		-52.17%
Net Earnings	$2.681M	-$1.080M	$1.125M
YoY Change	138.31%	-137.5%	-68.5%
Net Earnings / Revenue	5.99%	-2.83%	3.59%
Basic Earnings Per Share	$0.23	-$0.09	$0.10
Diluted Earnings Per Share	$0.23	-$0.09	$0.10
COMMON SHARES
Basic Shares Outstanding	11.55M shares		11.40M shares
Diluted Shares Outstanding	11.67M shares		11.54M shares

Balance Sheet

Concept	2017 Q2	2016 Q4	2016 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$8.400M	$27.40M	$15.00M
YoY Change	-44.0%	-82.29%	-91.0%
Cash & Equivalents	$8.369M	$27.37M	$20.02M
Short-Term Investments
Other Short-Term Assets	$2.700M	$3.600M	$4.000M
YoY Change	-32.5%	140.0%	-58.33%
Inventory	$42.31M	$26.18M	$25.10M
Prepaid Expenses	$2.676M	$3.564M
Receivables	$55.51M	$45.90M	$35.60M
Other Receivables	$4.000M	$0.00	$100.0K
Total Short-Term Assets	$112.9M	$103.0M	$79.80M
YoY Change	41.42%	-46.51%	-61.81%
LONG-TERM ASSETS
Property, Plant & Equipment	$14.97M	$11.00M	$8.900M
YoY Change	68.16%	54.23%	69.56%
Goodwill	$1.838M	$1.838M
YoY Change		0.0%
Intangibles	$196.6M	$175.8M
YoY Change		164.76%
Long-Term Investments
YoY Change
Other Assets	$32.90M	$0.00	$22.80M
YoY Change	44.3%	-100.0%	130.3%
Total Long-Term Assets	$246.4M	$219.9M	$228.2M
YoY Change	7.96%	137.22%	273.04%
TOTAL ASSETS
Total Short-Term Assets	$112.9M	$103.0M	$79.80M
Total Long-Term Assets	$246.4M	$219.9M	$228.2M
Total Assets	$359.2M	$322.9M	$308.0M
YoY Change	16.63%	13.18%	14.02%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.153M	$3.389M	$5.000M
YoY Change	-36.94%	64.04%	277.36%
Accrued Expenses	$1.565M	$927.0K	$16.50M
YoY Change	-90.52%	50.24%	323.08%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due		$0.00
YoY Change
Total Short-Term Liabilities	$28.29M	$31.95M	$24.70M
YoY Change	14.54%	171.76%	255.45%
LONG-TERM LIABILITIES
Long-Term Debt	$154.4M	$0.00	$117.0M
YoY Change	31.97%	-100.0%	2.9%
Other Long-Term Liabilities	$0.00	$600.0K	$2.500M
YoY Change	-100.0%
Total Long-Term Liabilities	$154.4M	$0.00	$119.5M
YoY Change	29.21%	-100.0%	5.1%
TOTAL LIABILITIES
Total Short-Term Liabilities	$28.29M	$31.95M	$24.70M
Total Long-Term Liabilities	$154.4M	$0.00	$119.5M
Total Liabilities	$182.7M	$153.2M	$144.2M
YoY Change	26.68%	22.39%	19.55%
SHAREHOLDERS EQUITY
Retained Earnings	$903.0K	-$2.916M
YoY Change		-32.97%
Common Stock	$1.000K	$1.000K
YoY Change		0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$176.5M	$169.6M	$163.8M
YoY Change
Total Liabilities & Shareholders Equity	$359.2M	$322.9M	$308.0M
YoY Change	16.63%	13.18%	14.02%

Cashflow Statement

Concept	2017 Q2	2016 Q4	2016 Q2
OPERATING ACTIVITIES
Net Income	$2.681M	-$1.080M	$1.125M
YoY Change	138.31%	-137.5%	-68.5%
Depreciation, Depletion And Amortization	$7.101M	$5.810M	$5.956M
YoY Change	19.22%	175.36%	320.92%
Cash From Operating Activities	$0.00	$12.08M	$3.340M
YoY Change	-100.0%	157.02%	176.03%
INVESTING ACTIVITIES
Capital Expenditures	-$2.300M	-$1.390M	-$720.0K
YoY Change	219.44%	26.36%	-116.74%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	-$60.31M
YoY Change	-100.0%		1240.22%
Cash From Investing Activities	-$2.310M	-$1.390M	-$61.03M
YoY Change	-96.21%	26.36%	30415.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-160.0K	520.0K	-30.00K
YoY Change	433.33%	188.89%	-118.75%
NET CHANGE
Cash From Operating Activities	0.000	12.08M	3.340M
Cash From Investing Activities	-2.310M	-1.390M	-61.03M
Cash From Financing Activities	-160.0K	520.0K	-30.00K
Net Change In Cash	-2.470M	11.21M	-57.72M
YoY Change	-95.72%	196.56%	-5033.33%
FREE CASH FLOW
Cash From Operating Activities	$0.00	$12.08M	$3.340M
Capital Expenditures	-$2.300M	-$1.390M	-$720.0K
Free Cash Flow	$2.300M	$13.47M	$4.060M
YoY Change	-43.35%	132.24%	-231.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8369000	USD
CY2017Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	55513000	USD
CY2017Q2	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2676000	USD
CY2017Q2	us-gaap	Goodwill Goodwill	1838000	USD
CY2017Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	5002000	USD
CY2017Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	0	USD
CY2017Q2	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	0	USD
CY2017Q2	anip	Accrued Government Rebates AccruedGovernmentRebates	3534000	USD
CY2017Q2	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	30000000	USD
CY2016Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	0	USD
CY2017Q2	us-gaap	Revenues Revenues	44764000	USD
CY2016Q2	us-gaap	Revenues Revenues	31337000	USD
CY2016Q2	us-gaap	Cost Of Revenue CostOfRevenue	11795000	USD
CY2016Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	764000	USD
CY2016Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7628000	USD
CY2016Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5956000	USD
CY2016Q2	us-gaap	Costs And Expenses CostsAndExpenses	26143000	USD
CY2016Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	5194000	USD
CY2016Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-2830000	USD
CY2016Q2	us-gaap	Net Income Loss NetIncomeLoss	1125000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2352000	USD
CY2016Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1227000	USD
CY2016Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.1
CY2016Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.1
CY2016Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11402000	shares
CY2016Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11541000	shares
CY2016Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-12000	USD
	us-gaap	Net Income Loss NetIncomeLoss	3833000	USD
	us-gaap	Net Income Loss NetIncomeLoss	2471000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3193000	USD
	us-gaap	Share Based Compensation ShareBasedCompensation	3322000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13807000	USD
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	10565000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3790000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	3482000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9618000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	13630000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-776000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	807000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-836000	USD
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1992000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-345000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	2850000	USD
	anip	Increase Decrease In Accrued Compensation Liabilities IncreaseDecreaseInAccruedCompensationLiabilities	-404000	USD
	anip	Increase Decrease In Accrued Compensation Liabilities IncreaseDecreaseInAccruedCompensationLiabilities	-117000	USD
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-6389000	USD
	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	977000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	13000	USD
	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	2658000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	50956000	USD
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	144494000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	4442000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2088000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	131000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27365000	USD
CY2016Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	45895000	USD
CY2017Q2	us-gaap	Inventory Net InventoryNet	42307000	USD
CY2016Q4	us-gaap	Inventory Net InventoryNet	26183000	USD
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	175901000	USD
CY2016Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3564000	USD
CY2017Q2	us-gaap	Assets Current AssetsCurrent	112856000	USD
CY2016Q4	us-gaap	Assets Current AssetsCurrent	103007000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	14966000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	10998000	USD
CY2017Q2	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	27933000	USD
CY2016Q4	us-gaap	Deferred Tax Assets Net Noncurrent DeferredTaxAssetsNetNoncurrent	26227000	USD
CY2017Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	196624000	USD
CY2016Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	175792000	USD
CY2016Q4	us-gaap	Goodwill Goodwill	1838000	USD
CY2017Q2	us-gaap	Assets Assets	359219000	USD
CY2016Q4	us-gaap	Assets Assets	322864000	USD
CY2017Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	3153000	USD
CY2016Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3389000	USD
CY2017Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1565000	USD
CY2016Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	927000	USD
CY2017Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1227000	USD
CY2016Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1631000	USD
CY2017Q2	anip	Returned Goods Reserve ReturnedGoodsReserve	7558000	USD
CY2016Q4	anip	Returned Goods Reserve ReturnedGoodsReserve	5756000	USD
CY2017Q2	us-gaap	Liabilities Current LiabilitiesCurrent	28292000	USD
CY2016Q4	us-gaap	Liabilities Current LiabilitiesCurrent	31948000	USD
CY2017Q2	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2017Q2	anip	Class C Special Stock Value ClassCSpecialStockValue	0	USD
CY2016Q4	anip	Class C Special Stock Value ClassCSpecialStockValue	0	USD
CY2017Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	172563000	USD
CY2017Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	903000	USD
CY2016Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2916000	USD
CY2017Q2	us-gaap	Stockholders Equity StockholdersEquity	176546000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	169648000	USD
CY2017Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	359219000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	322864000	USD
CY2017Q2	us-gaap	Liabilities Liabilities	182673000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	153216000	USD
CY2017Q2	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	124381000	USD
CY2016Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	120643000	USD
CY2017Q2	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	11255000	USD
CY2016Q4	us-gaap	Accrued Royalties Current AccruedRoyaltiesCurrent	11956000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	5002000	USD
CY2016Q4	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	625000	USD
CY2016Q4	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	2398000	USD
CY2016Q4	anip	Accrued Government Rebates AccruedGovernmentRebates	5891000	USD
CY2017Q2	us-gaap	Cost Of Revenue CostOfRevenue	21122000	USD
CY2017Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2167000	USD
CY2017Q2	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	7380000	USD
CY2017Q2	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	7101000	USD
CY2017Q2	us-gaap	Costs And Expenses CostsAndExpenses	37770000	USD
CY2017Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	6994000	USD
CY2017Q2	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-3025000	USD
CY2017Q2	us-gaap	Net Income Loss NetIncomeLoss	2681000	USD
CY2017Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3950000	USD
CY2017Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1269000	USD
CY2017Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2017Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2017Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11546000	shares
CY2017Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11667000	shares
CY2017Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-19000	USD
	anip	Increase Decrease In Returned Goods Reserve IncreaseDecreaseInReturnedGoodsReserve	661000	USD
	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	2423000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-435000	USD
CY2016Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	32367000	USD
CY2015Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	154684000	USD
CY2017Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	13371000	USD
CY2015Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	USD
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	116000	shares
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	504000	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	0	USD
	us-gaap	Excess Tax Benefit From Share Based Compensation Financing Activities ExcessTaxBenefitFromShareBasedCompensationFinancingActivities	19000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	9882000	USD
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2206000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	109000	USD
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	45000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	6530000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	14306000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-55398000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-146582000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29872000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2393000	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	USD
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	2500000	USD
	us-gaap	Increase Decrease In Royalties Payable IncreaseDecreaseInRoyaltiesPayable	-701000	USD
	anip	Increase Decrease In Returned Goods Reserve IncreaseDecreaseInReturnedGoodsReserve	1802000	USD
	anip	Increase Decrease Accrued Government Rebates IncreaseDecreaseAccruedGovernmentRebates	-2357000	USD
	anip	Increase Decrease Accrued Government Rebates IncreaseDecreaseAccruedGovernmentRebates	1878000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	30000000	USD
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	0	USD
	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	-18996000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	154684000	USD
	anip	Accrued Royalties Related To Asset Purchase AccruedRoyaltiesRelatedToAssetPurchase	3882000	USD
	anip	Accrued Royalties Related To Asset Purchase AccruedRoyaltiesRelatedToAssetPurchase	0	USD
CY2016Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20015000	USD
CY2016Q2	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	5001000	USD
CY2017Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	143750000	USD
CY2017Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	17328000	USD
CY2017Q2	us-gaap	Long Term Debt LongTermDebt	124381000	USD
CY2016Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	143750000	USD
CY2016Q4	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	20644000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	120643000	USD
CY2017Q2	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2041000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	2463000	USD
CY2017Q2	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	1078000	USD
CY2017Q2	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1668000	USD
CY2017Q2	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	211000	USD
CY2017Q2	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	134000	USD
CY2017Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	30000000	USD
CY2017Q1	us-gaap	Line Of Credit Facility Maximum Borrowing Capacity LineOfCreditFacilityMaximumBorrowingCapacity	40000000	USD
CY2017Q2	us-gaap	Line Of Credit LineOfCredit	30000000	USD
CY2017Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4800000	shares
CY2016Q2	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4500000	shares
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	3833000	USD
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2471000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3805000	USD
	us-gaap	Deferred Income Taxes And Tax Credits DeferredIncomeTaxesAndTaxCredits	-1706000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1117000	USD
CY2016Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	1117000	USD
CY2016Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	139000	shares
CY2016Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	14138000	USD
CY2017Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5970000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	26825000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	26825000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	26343000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	24898000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	78231000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	13502000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	3805000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2454000	USD
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11536000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11398000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	123000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11659000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11514000	shares
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.22
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.21
CY2017Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	2681000	USD
CY2016Q2	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	1125000	USD
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2661000	USD
CY2017Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	2661000	USD
CY2017Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	121000	shares
CY2017Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	17183000	USD
CY2017Q2	us-gaap	Retail Related Inventory Packaging And Other Supplies RetailRelatedInventoryPackagingAndOtherSupplies	1279000	USD
CY2016Q4	us-gaap	Retail Related Inventory Packaging And Other Supplies RetailRelatedInventoryPackagingAndOtherSupplies	930000	USD
CY2017Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	23279000	USD
CY2016Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	10812000	USD
CY2017Q2	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	210000	USD
CY2016Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	174000	USD
CY2017Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	776000	USD
CY2016Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	477000	USD
CY2017Q2	us-gaap	Depreciation Depreciation	300000	USD
CY2016Q2	us-gaap	Depreciation Depreciation	200000	USD
CY2016Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5387000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	196624000	USD
	us-gaap	Fair Value Inputs Discount Rate FairValueInputsDiscountRate	0.15	pure
CY2017Q2	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	300000	USD
	dei	Document Type DocumentType	10-Q
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2017-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Registrant Name EntityRegistrantName	ANI PHARMACEUTICALS INC
	dei	Entity Central Index Key EntityCentralIndexKey	0001023024
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
	dei	Trading Symbol TradingSymbol	ANIP
CY2017Q2	us-gaap	Prepaid Taxes PrepaidTaxes	3991000	USD
CY2016Q4	us-gaap	Prepaid Taxes PrepaidTaxes	0	USD
CY2017Q2	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	259000	USD
CY2016Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	0	USD
CY2017Q2	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	39050000	USD
CY2016Q4	us-gaap	Valuation Allowances And Reserves Balance ValuationAllowancesAndReservesBalance	31535000	USD
	us-gaap	Use Of Estimates UseOfEstimates	<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px 0pt 0.25in"> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px 0pt 0.25in"> <b>Use of Estimates</b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px 0pt 0.25in">  </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px 0pt 0.25in"> The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenues and expenses during the reporting period. In the accompanying unaudited interim condensed consolidated financial statements, estimates are used for, but not limited to, stock-based compensation, allowance for doubtful accounts, accruals for chargebacks, administrative fees and rebates, government rebates, returns and other allowances, allowance for inventory obsolescence, valuation of financial instruments and intangible assets, accruals for contingent liabilities, fair value of long-lived assets, deferred taxes and valuation allowance, purchase price allocations, and the depreciable lives of long-lived assets. Because of the uncertainties inherent in such estimates, actual results may differ from those estimates. Management periodically evaluates estimates used in the preparation of the financial statements for reasonableness.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2017Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2017Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1666667	shares
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1666667	shares
CY2017Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	5203	shares
CY2016Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	0	shares
	us-gaap	Revenues Revenues	81392000	USD
	us-gaap	Revenues Revenues	51892000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	37508000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	15205000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3785000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1730000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	14673000	USD
	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	13532000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	69773000	USD
	us-gaap	Costs And Expenses CostsAndExpenses	41032000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	11619000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	10860000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-5957000	USD
	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	-5612000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-37000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-10000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5625000	USD
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5238000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1792000	USD
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2767000	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	USD
	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	294000	USD
	anip	Payment For Treasury Stock Purchases For Restricted Stock Vestings And Forfeitures PaymentForTreasuryStockPurchasesForRestrictedStockVestingsAndForfeitures	259000	USD
	anip	Payment For Treasury Stock Purchases For Restricted Stock Vestings And Forfeitures PaymentForTreasuryStockPurchasesForRestrictedStockVestingsAndForfeitures	122000	USD
	us-gaap	Interest Paid Net InterestPaidNet	2097000	USD
	us-gaap	Interest Paid Net InterestPaidNet	2056000	USD
CY2017Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	2823000	USD
CY2016Q2	us-gaap	Interest Expense Debt InterestExpenseDebt	2817000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	5669000	USD
	us-gaap	Interest Expense Debt InterestExpenseDebt	5622000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	2156000	USD
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	2156000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3315000	USD
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	3144000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	422000	USD
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	422000	USD
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	224000	USD
	us-gaap	Interest Costs Capitalized Adjustment InterestCostsCapitalizedAdjustment	100000	USD
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4700000	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	4500000	shares
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	100000	USD
CY2017Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20936000	USD
CY2016Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	16385000	USD
CY2017Q2	us-gaap	Inventory Gross InventoryGross	42517000	USD
CY2016Q4	us-gaap	Inventory Gross InventoryGross	26357000	USD
	us-gaap	Depreciation Depreciation	600000	USD
	us-gaap	Depreciation Depreciation	400000	USD
CY2017Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	100000	USD
CY2016Q2	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	54000	USD
	us-gaap	Interest Costs Capitalized InterestCostsCapitalized	200000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	238048000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	203992000	USD
CY2017Q2	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	41424000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	28200000	USD
CY2017Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	6800000	USD
CY2016Q2	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	5700000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	13200000	USD
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10100000	USD
	anip	Acquired Finitelived Intangible Asset Amortization Description AcquiredFinitelivedIntangibleAssetAmortizationDescription	we are amortizing 80% of the value of the intangible assets over the first five years of useful lives of the assets and amortizing the remaining 20% of the value of the intangible assets over the second five years of useful lives of the assets.
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3322000	USD
CY2017Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1779000	USD
CY2016Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2217000	USD
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3150000	USD
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.319	pure
	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.528	pure
CY2017Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.321	pure
CY2016Q2	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.522	pure
	anip	Percentage Of Royalties On Net Sales Of Unapproved Products PercentageOfRoyaltiesOnNetSalesOfUnapprovedProducts	less than 1%
	anip	Percentage Of Royalties On Net Sales Of Unapproved Products PercentageOfRoyaltiesOnNetSalesOfUnapprovedProducts	less than 1%
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q2	anip	Percentage Of Royalties On Net Sales Of Unapproved Products PercentageOfRoyaltiesOnNetSalesOfUnapprovedProducts	less than 1%
CY2016Q2	anip	Percentage Of Royalties On Net Sales Of Unapproved Products PercentageOfRoyaltiesOnNetSalesOfUnapprovedProducts	less than 1%
CY2016Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	300000	USD

Files In Submission

Name	View Source	Status
0001144204-17-040342-index-headers.html	Edgar Link	pending
0001144204-17-040342-index.html	Edgar Link	pending
0001144204-17-040342.txt	Edgar Link	pending
0001144204-17-040342-xbrl.zip	Edgar Link	pending
anip-20170630.xml	Edgar Link	completed
anip-20170630.xsd	Edgar Link	pending
anip-20170630_cal.xml	Edgar Link	unprocessable
anip-20170630_def.xml	Edgar Link	unprocessable
anip-20170630_lab.xml	Edgar Link	unprocessable
anip-20170630_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
v471248_10q.htm	Edgar Link	pending
v471248_ex31-1.htm	Edgar Link	pending
v471248_ex31-2.htm	Edgar Link	pending
v471248_ex32-1.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ANIP
ANI Pharmaceuticals Inc Stock $anip

2017 Q2 Form 10-Q Financial Statement

#000114420417040342 Filed on August 03, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ANIP ANI Pharmaceuticals Inc Stock $anip

2017 Q2 Form 10-Q Financial Statement

#000114420417040342 Filed on August 03, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ANIP
ANI Pharmaceuticals Inc Stock $anip